학술논문
Phase 2, multicenter, open-label basket trial of nab -sirolimus for patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (PRECISION I).
Document Type
Article
Author
Iyer, Gopa; Deming, Dustin A.; Demeure, Michael J.; Federman, Noah; McKean, Meredith; Lee, Elizabeth Katherine; Spira, Alexander I.; Kwiatkowski, David J.; Hussein, Maen A.; Gordon, Erlinda Maria; Crockett, David G.; Ganjoo, Kristen N.; Schulte, Brian; Cranmer, Lee D.; Ding, Li; Schmid, Anita N.; Navarro, Willis H.; Rodon Ahnert, Jordi
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS3168-TPS3168, 1p
Subject
Language
ISSN
0732183X